Journey Medical Corp (DERM)

NASDAQ

$7.09

Dermira, Inc., a biopharmaceutical company, develops and markets therapies for patients with dermatological diseases in the United States.

Sector:

Industry:

68 analysts

Buy

Target: $13.50 (+90.41%)

Market Cap

$199M

Free Cash Flow Yield

-3.38%

Beta (5Y)

1.12

Adjust inflation

Log

Valuation

Market Cap$199M

Forward P/E212.77

P/S3.10

P/B6.36

Profitability

Total Revenue (TTM)$64M

Gross Profit (TTM)$42M

EBITDA-$5.83M

Profit Margin-14%

Operating Margin-9.4%

EPS-$0.52

Financial Health

Debt-to-Equity82.3%

Free Cash Flow Yield-3.38%

Growth & Risk

Beta (5Y)1.12

Sharpe Ratio0.23